Evidence map›Paper›PMID 31588501›Full record

ArticleThe Journal of clinical endocrinology and metabolism2020

Regulation of Insulin-Like Growth Factor 2 by Oocyte-Secreted Factors in Primary Human Granulosa Cells.

Elie Hobeika, Marah Armouti, Michele A Fierro, Nichola Winston, Humberto Scoccia, Alberuni M Zamah, Carlos Stocco

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elie HobeikaDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Illinois at Chicago College of Medicine, Chicago, Illinois.
Marah ArmoutiDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, Illinois.
Michele A FierroDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Illinois at Chicago College of Medicine, Chicago, Illinois.
Nichola WinstonDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Illinois at Chicago College of Medicine, Chicago, Illinois.
Humberto ScocciaDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Illinois at Chicago College of Medicine, Chicago, Illinois.
Alberuni M ZamahDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, the University of Chicago Medicine, Chicago, Illinois.
Carlos StoccoDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, Illinois.
University of Illinois Chicago · USUniversity of Chicago · US

Funding

Salt-Inducible Kinase Regulation of Ovarian Granulosa CellsR01HD097202 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI STOCCO, CARLOS OSCAR · 2019 to 2023
$1.7M
FSH and IGF1R signaling Crosstalk in Ovarian GCsR56HD086054 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI STOCCO, CARLOS OSCAR · 2016 to 2016
$300k
NICHD NIH HHS R01 HD097202NICHD NIH HHS R56 HD086054
6 · The paper itself

Abstract

contextHuman granulosa cells (hGCs) produce and respond to insulin-like growth factor 2 (IGF2) but whether the oocyte participates in IGF2 regulation in humans is unknown.

objectiveTo determine the role of oocyte-secreted factors (OSFs) such as growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) in IGF2 production by hGCs.

designPrimary human cumulus GCs in culture.

settingUniversity infertility center. PATIENTS OR OTHER

participantsGCs of women undergoing in vitro fertilization. INTERVENTION(S): Cells treated with GDF9 and BMP15 in the presence of vehicle, follicle-stimulating hormone (FSH), dibutyryl cyclic-AMP (dbcAMP), or mothers against decapentaplegic homolog (SMAD) inhibitors. MAIN OUTCOME MEASURE(S): Quantification of mRNA, protein, promoter activity, and DNA methylation.

resultsFSH stimulation of IGF2 (protein and mRNA) was significantly potentiated by the GDF9 and BMP15 (G+B) combination (P < 0.0001) in a concentration-dependent manner showing a maximal effect at 5 ng/mL each. However, GDF9 or BMP15 alone or in combination (G+B) have no effect on IGF2 in the absence of FSH. FSH stimulated IGF2 promoter 3 activity, but G+B had no effect on promoter activity. G+B potentiated IGF2 stimulation by cAMP. SMAD3 inhibitors inhibited G+B enhancement of IGF2 stimulation by FSH (P < 0.05) but had no effect on FSH induction. Moreover, inhibition of insulin-like growth factor receptor partially blocked G+B potentiation of FSH actions (P < 0.009).

conclusionsFor the first time, we show that the oocyte actively participates in the regulation of IGF2 expression in hGCs, an effect that is mediated by the specific combination of G+B via SMAD2/3, which in turn target mechanisms downstream of the FSH receptor.

Indexed as

Bone Morphogenetic Protein 15Cells, CulturedCulture Media, ConditionedCyclic AMPDrug CombinationsFemaleFollicle Stimulating HormoneGene Expression RegulationGranulosa CellsGrowth Differentiation Factor 9HumansInsulin-Like Growth Factor IIOocytesPrimary Cell CultureBone Morphogenetic Protein 15Culture Media, ConditionedCyclic AMPDrug CombinationsFollicle Stimulating HormoneGDF9 protein, humanGrowth Differentiation Factor 9IGF2 protein, humanInsulin-Like Growth Factor II

Identifiers

PMID31588501
PMCPMC6938692
OpenAlexW2979525565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.